Research Continues To Develop Safe, Effective Ebola Vaccine

Media sources report on efforts to develop a vaccine to treat or prevent Ebola.

CIDRAP News: At symposium, vaccine seen as best hope for arresting Ebola
“At a wide-ranging symposium on West Africa’s Ebola epidemic [Tuesday], much of the attention focused on the hope of an effective vaccine, as a U.S. official announced that a large clinical trial of two candidate vaccines may be launched in Liberia in December…” (Roos, 10/14).

National Geographic: Long Quest for Ebola Vaccine Slowed by Science, Ethics, Politics
“Ebola vaccines are so effective in monkeys that macaques can be protected or rescued even if they’re injected with a hundred times the lethal dose of the Ebola virus after vaccination. But no one knows for certain whether the vaccines will work in humans; the vaccines haven’t yet been rigorously tested in people…” (Weintraub, 10/14).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

The Henry J. Kaiser Family Foundation Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KaiserFamilyFoundation | twitter.com/kff

Filling the need for trusted information on national health issues, the Kaiser Family Foundation is a nonprofit organization based in San Francisco, California.